Welcome to my review of a presentation that was recently put out by Brownstone Research with the header “Stunning Confession.”
From only reading the header, you can tell that it concerns a little-known technology that helped save Jeff Brown’s (he is the subject of the sentence) life and that can potentially be the number #1 investment opportunity of 2021.
In this article, we will find out what little-known technology he is talking about as well as the investment opportunities Jeff wants us to consider.
Before I start…
If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.
It’s helped me earn over $300,000 in the last 12 months alone:
Go here to see my no.1 recommendation for making money online
(This is a 100% free training)
Jeff Browns Stunning Confession Review
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Introduction to Jeff Browns Stunning Confession
The presentation begins on a sad note as Jeff informs us that he has prostate cancer — that has to be the stunning confession he refers to because nothing else can be as important as that. I hope he recovers fully and continues to lead a healthy life.
He learned about it while he was researching a biotech company. He was put under a machine that revealed he had cancer.
What does his diagnosis have to do with investing?
It all leads to a new underlying trend that is simmering in the biotech industry; precision medicine.
According to the Precision Medicine Initiative, precision medicine is a new approach to treatment and prevention that takes into consideration individual variability in genes, environment, and lifestyle rather than the one-size-fits-all approach we’ve had till now.
He says that precision medicine is a gamechanger in the medical industry that will save millions of lives and billions of dollars as patients get more specific treatments. I should mention that this is not the first time that Jeff has talked about investing in biotech as we’ve seen him do so in presentations like Biotech Profits Stock and Miracle Cure Antibiotic.
How to Invest in Precision Medicine The Jeff Brown Way
To invest in the new trend, Jeff wants you to look at precision medicine as a confluence of many disruptive technologies. Therefore, to invest in it, you need to take each underlying technology and identify the companies involved and invest in them.
Basically, he wants you to invest in the pick and shovel companies of precision medicine.
The first one is in genetic sequencing. It is working on reducing the costs of genetic sequencing and currently controls roughly 75% of the global market. Its equipment is used by healthcare stakeholders to sequence patient DNA and the FDA issued it with an emergency use authorization designation. Jeff wrote a report about it called The #1 Precision Medicine Stock of the 2020s. After a bit of research, I think he is referring to Illumina Inc (ILMN).
The second company in the aforementioned special report has 30 products in clinical development and its top selling drug earned $5 in the US alone. It was also issued an emergency use authorization by the FDA and it was behind the antibody cocktail that was given to former President Trump when he had the coronavirus in October. The company that fits this description is Regeneron Pharmaceuticals Inc. (REGN).
The third company Jeff teases deals with Cystic Fibrosis Therapeutics. It has had four drugs approved for cystic fibrosis since 2012 and three of them have helped up to 90% of people who have the disease. It partnered with a gene-editing company in 2015. He wrote a report on it called The Company Behind Cystic Fibrosis’ Demise but you don’t have to read that because the company that fits this description is Vertex Pharmaceuticals (VTRX).
The fourth company is not a biotech company. It started developing 5G products in 2014 and has been developing products for AI, machine learning, and quantum computing. 24 of the top 25 tech companies in the world use its proprietary tech and it currently produces the equipment used to gather test results for 5G devices. Jeff wrote a report called My #1 Stock “Behind” Quantum Computing’s Rise but you don’t have to read that because I think he is referring to a company called Teradyne (TER).
There is a fifth company he teases that develops therapy for hemophiliacs. It concentrates on hemophilia A and it recently announced that it developed a therapy that had a positive impact. In a study of over 100 patients, it reduced the average annual treatments from 136 to just 2. He wrote a report about it called My #1 Gene Therapy Stock. The stock that I think he was teasing is BioMarin Pharmaceutical (BMRN).
Note that although I have “revealed” the names of the companies that were teased, these are not definitive and I encourage you to conduct further research before you make an investment.
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Who is Jeff Brown?
Jeff Brown is one of the most well-known angel investors in Silicon Valley. He is the founder of Brownstone Research.
He has vast knowledge of the tech industry ranging from self-driving cars, 5G, artificial intelligence, cryptocurrencies, and more. He predicts what he thinks are the best tech stock investment opportunities every year.
Jeff used to work as an executive for some of the world’s most recognizable technology firms for thirty years. He was worked as the Head of Global Strategy and Development at Qualcomm and has worked for NXP Semiconductors.
He has an MBA from the London Business School and got his undergraduate degree in engineering from Purdue University.
RECOMMENDED: Go here to see my no.1 recommendation for making money online
How to access Jeff Brown’s special reports
To get your hands on the aforementioned special reports for free to reveal the names of the stocks that Jeff was teasing, you have to sign up for a newsletter that he offers called Near Future Report. Just to recap, the special reports I am referring to are…
- The #1 Precision Medicine Stock of the 2020s.
- The Company Behind Cystic Fibrosis’ Demise.
- My #1 Stock “Behind” Quantum Computing’s Rise.
- My #1 Gene Therapy Stock
In addition to the reports, other benefits to signing up for the newsletter include…
- 12 Monthly Issues of The Near Future Report
- Access to all past and future reports for free
- Members-Only Portfolio Access 24/7
- Access to U.S. Based Customer Service
Subscription Price: $49 for the first year if you join via the presentation. It renews at $129 per year after that (for all members including those who pay $49 in the first year)
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Is Jeff Browns Stunning Confession Legit?
Yes, Jeff Browns Stunning Confession is a legit presentation because it was published by a legit publishing company and by an investment guru whose work we have encountered before. He uses the presentation to reveal how he intends to invest in biotech stocks and there’s nothing wrong with that.
You may not agree with his approach but it doesn’t mean that it is not legit. That being said, take everything he says with a grain of salt.
Jeff Browns Stunning Confession Verdict
Jeff Brown’s Stunning Confession webinar is an ad for the Near Future Report. Before he promotes it, he talks about investing in the biotech industry (precision medicine) and teases a few companies that he thinks are perfectly positioned to do well.
Jeff has been urging his readers to invest in biotech stocks and points to his track record to prove the efficacy of his approach. Nevertheless, do not just sign up for his newsletter based on his past performances because they are not a good indicator of how he will do moving forward. Do further research before you sign up for a newsletter as it is the best way to find out whether it is suited to your personal approach.
Before you leave
If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.
It’s helped me earn over $300,000 in the last 12 months alone:
Go here to see my no.1 recommendation for making money online
(This is a 100% free training)
David Fortune has been the editor NoBSIMReviews.com since 2019. He is an expert at writing content on stock advisory services, side hustles, reviewing online business opportunities and many more topics. You can learn more about David on our about us page.